Product correctly added to cart.

discount label
5-Bromo-2-cyano-3-nitropyridine
View 3D

Biosynth logo

5-Bromo-2-cyano-3-nitropyridine

CAS: 573675-25-9

Ref. 3D-NB67409

10g
100.00 €
25g
179.00 €
50g
305.00 €
100g
479.00 €
250g
1,007.00 €
Estimated delivery in United States, on Tuesday 11 Jun 2024

Product Information

Name:
5-Bromo-2-cyano-3-nitropyridine
Synonyms:
  • 5-Bromo-3-nitropyridine-2-carbonitrile
Description:

5-Bromo-2-cyano-3-nitropyridine is a medication that has been shown to be an effective inhibitor of the RET tyrosine kinase. It has been used in clinical studies to treat chronic kidney disease and has been shown to inhibit the growth of cancer cells. The molecular electrostatic potential (MEP) simulations have shown that 5-bromo-2-cyano-3-nitropyridine interacts with the reactive site of RET, inhibiting its function by binding to the nucleophilic substitutions. 5-Bromo-2-cyano-3-nitropyridine is synthesized from 2,5 dibromopyridine and 3 nitrobenzene at high yield. The molecule is chromatographically separated from impurities such as 4 bromo pyridine.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
228 g/mol
Formula:
C6H2BrN3O2
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NB67409 5-Bromo-2-cyano-3-nitropyridine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".